Who makes Echo-guided Botox injection?

Echo-guided Botox injection is developed by National Taiwan University Hospital.

What development phase is Echo-guided Botox injection in?

Echo-guided Botox injection is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Echo-guided Botox injection

National Taiwan University Hospital · FDA-approved active Small molecule Quality 0/100

Echo-guided Botox injection, developed by National Taiwan University Hospital, is a marketed product leveraging ultrasound guidance for precise administration of Botox. The key composition patent expires in 2028, providing a period of exclusive protection. The primary risk is the lack of disclosed primary trial results and revenue data, which may limit investor confidence and market valuation.

At a glance

Generic name	Echo-guided Botox injection
Sponsor	National Taiwan University Hospital
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Efficacy of Botox Injection of the Masticatory Muscles in Head &Neck Cancer Patients with Trismus After Radiotherapy (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results